Men suspected of having prostate cancer may soon receive diagnoses within a day, thanks to a new trial being conducted by the NHS. This initiative, described as a “game-changer,” leverages artificial intelligence to analyze MRI scans in mere seconds.
Participants identified as high-risk for cancer will be promptly referred to specialists for quick evaluations, which will be followed by biopsies. The results of these biopsies are expected to be available on the same day, allowing cancer-free patients to receive their all-clear status within hours. For those with a positive diagnosis, results will be communicated as soon as the following day, according to The Telegraph.
Currently, men awaiting results from their screenings can experience delays of up to a month after being referred for biopsy procedures. The new approach aims to significantly reduce this waiting period, enhancing the overall patient experience.
This move comes amid concerns that many men who are most in need of prostate testing are not receiving them. The combination of AI technology and expedited review processes could lead to earlier intervention and improved outcomes for patients facing prostate cancer.
